Certara (CERT) Competitors

Certara (NASDAQ:CERT) and NICE (NASDAQ:NICE) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership, earnings and community ranking.

Does the media prefer CERT or NICE?

In the previous week, NICE had 26 more articles in the media than Certara. MarketBeat recorded 37 mentions for NICE and 11 mentions for Certara. Certara's average media sentiment score of 1.05 beat NICE's score of 0.89 indicating that Certara is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NICE	18 Very Positive mention(s)	8 Positive mention(s)	5 Neutral mention(s)	3 Negative mention(s)	1 Very Negative mention(s)	Positive

Is CERT or NICE more profitable?

NICE has a net margin of 16.18% compared to Certara's net margin of -8.34%. NICE's return on equity of 16.17% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-8.34%	3.43%	2.33%
NICE	16.18%	16.17%	11.11%

Do analysts recommend CERT or NICE?

Certara presently has a consensus target price of $15.17, suggesting a potential upside of 9.43%. NICE has a consensus target price of $224.29, suggesting a potential upside of 43.91%. Given NICE's stronger consensus rating and higher probable upside, analysts clearly believe NICE is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
NICE	0 Sell rating(s)	4 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.75

Which has more risk and volatility, CERT or NICE?

Certara has a beta of 1.64, indicating that its share price is 64% more volatile than the S&P 500. Comparatively, NICE has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500.

Do institutionals & insiders have more ownership in CERT or NICE?

74.0% of Certara shares are owned by institutional investors. Comparatively, 63.3% of NICE shares are owned by institutional investors. 2.3% of Certara shares are owned by company insiders. Comparatively, 0.0% of NICE shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Which has better earnings and valuation, CERT or NICE?

NICE has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than NICE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$385.15M	5.81	-$55.36M	-$0.08	-173.25
NICE	$2.74B	3.58	$338.30M	$6.76	23.05

Does the MarketBeat Community believe in CERT or NICE?

NICE received 656 more outperform votes than Certara when rated by MarketBeat users. Likewise, 69.77% of users gave NICE an outperform vote while only 34.18% of users gave Certara an outperform vote.

Company	Underperform	Outperform
Certara	Outperform Votes 27 34.18%	Underperform Votes 52 65.82%
NICE	Outperform Votes 683 69.77%	Underperform Votes 296 30.23%

Summary

NICE beats Certara on 13 of the 18 factors compared between the two stocks.